Introduction {#section1-1559325818805838}
============

Computed tomography coronary angiography (CTCA) has emerged as the elective noninvasive imaging modality to rule out the presence of significant obstructive coronary artery disease (CAD); thanks to its high negative predictive value.^[@bibr1-1559325818805838]^ This imaging modality allows to characterize coronary plaques and assess the atherosclerotic burden and stenosis severity, hence playing a key role for patient risk stratification.^[@bibr2-1559325818805838]^ The handling of the acquired data allows a versatile postprocessing such as maximum intensity projections (MIPs), curved multiplanar reformations (c-MPRs), and 3D volume rendering (VR) that define the vessel course and its anatomical relationships with the surrounding structures.^[@bibr3-1559325818805838],[@bibr4-1559325818805838]^ However, the expanding application of CTCA has raised concerns about radiation exposure, since it has been widely demonstrated to be related to an eventual increased risk of carcinogenesis.^[@bibr5-1559325818805838],[@bibr6-1559325818805838]^ Several strategies have been developed to reduce patient radiation exposure, such as retrospective electrocardiogram (ECG) pulsing acquisition with tube current modulation, prospectively ECG-gated CTCA also called step and shoot mode (SAS), and high pitch spiral mode (FLASH).^[@bibr7-1559325818805838]^ Lowering of radiation dose is therefore a clinical priority that has to be balanced with the need to obtain diagnostic examinations according to the principle of dose optimization. Moreover, in order to have an adequate image quality, these low-dose acquisition methods require a low and stable heart rate (HR), which is not always possible to obtain in all patients.^[@bibr8-1559325818805838][@bibr9-1559325818805838][@bibr10-1559325818805838]-[@bibr11-1559325818805838]^ The purpose of this study was to compare image quality and radiation dose using different CTCA scan protocols with a second-generation dual source CT (DSCT) scanner in order to define the parameters for an efficient fine-tuning of a CTCA examination.

Materials and Methods {#section2-1559325818805838}
=====================

Study Population {#section3-1559325818805838}
----------------

The anonymized records of 90 patients who underwent a 128-slice DSCT-CTCA were retrospectively examined. Patients with history of percutaneous intervention and/or bypass surgery and persistent arrhythmias were excluded. Thirteen patients had typical chest pain, 32 patients had atypical chest pain, 23 patients had nonanginal symptoms, and 22 patients were asymptomatic. Different protocols (FLASH, SAS, and retrospective) were selected according to patient's HR at presentation. Patients were divided into 3 groups: group A (FLASH) composed by 26 patients with stable HR ≤60 bpm; group B (SAS with acquisition during 66%-75% of RR \[inter-beat\] interval) composed of 48 patients with irregular HR ≤60 bpm or stable HR between 60 and 70 bpm; and group C (retrospective ECG pulsing modulation acquisition) composed of 16 patients with irregular HR \>60 bpm or stable HR ≥70 bpm. Informed consent was obtained from all patients.

Computed Tomography Acquisition and Image Reconstruction {#section4-1559325818805838}
--------------------------------------------------------

Imaging was performed with a DSCT system (Definition FLASH, Siemens Healthcare, Forchheim, Germany). All patients underwent a sequential scan before contrast administration for preliminary quantification of calcium score with the Agatston method (slice thickness: 3 mm, slice increment: 3 mm, a medium smooth reconstruction kernel (B36f)). Calcium score was evaluated with a dedicated software (CaScore; Siemens, Germany).

Therefore, CTCA was performed with intravenous contrast enhancement. Contrast medium was injected in the antecubital vein using a dual head power injector (Stellant; Medrad, Indianola, Pennsylvania). To synchronize the acquisition of the CTCA data set to the arterial enhancement, a "test bolus" protocol was used: 10 mL of contrast agent of iopromide (Ultravist 370, 370 mgI/mL, Bayer Schering Pharma, Berlin, Germany) were followed by 60 mL of saline solution, both at flow rates of 5 to 6 mL/s, and the time to peak enhancement in the aorta was measured using a series of transaxial scans acquired at 2-second increments, with the first image being acquired 15 seconds after the start of injection. During CTCA, all patients received a dose of 60 mL of contrast agent injected at a flow rate of 5 to 6 mL/s followed by 60 mL of saline solution. Image acquisition was started with a delay corresponding to the measured contrast transit time plus 5 seconds. For FLASH mode, pitch was between 3.2 and 3.4 (table feed: 46 cm/s). Image acquisition was prospectively triggered by patient ECG and started at 60% of the R--R interval. The total duration of data acquisition was dependent on the selected pitch value and the length of the scan volume and varied between 220 and 300 milliseconds. For SAS mode, the triggering phase was set at 66% to 75% of RR interval. For spiral mode, pitch was automatically adapted to HR, and a radiation exposure-modulation algorithm (ECG pulsing) was used to minimize the radiation dose outside the pulsing temporal window. Full exposure was set to 35% to 75% of the RR interval and decreased to 20% of the peak mAs outside this temporal window. The kV and mA were adapted to patient size by automatic exposure control. Reconstructed slice thickness was 0.6 mm, slice increment was 0.3 mm, a medium soft reconstruction kernel was used (B26f), and the field of view was 20 cm.

Subjective and Objective Image Quality {#section5-1559325818805838}
--------------------------------------

For analysis, image data sets were transferred to an off-line workstation (Multimodality Workplace; Siemens Healthcare). Both objective image quality and subjective image quality were assessed for all patients. Subjective image quality was independently evaluated on a per-vessel basis by 2 independent physicians with experience in cardiovascular imaging of more than 5 years. During the CT image interpretation session, the overall quality of axial slices, MPR, c-MPR, MIP and VR were assessed. A 4-point scale was used (1 excellent = absence of artifacts; 2 good = minimal artifacts, mild blurring or structure discontinuity but fully evaluable; 3 suboptimal = moderate artifacts and blurring or structure discontinuity; 4 not diagnostic = doubling or discontinuity in the course of the segment preventing diagnostic evaluation; [Figure 1](#fig1-1559325818805838){ref-type="fig"}).^[@bibr12-1559325818805838]^ In case of disagreement between the observers, consensus was reached in a joint reading to determine the final image quality score. A per-patient image quality score was defined as the worst score found in any coronary artery for each patient.

![Curved multiplanar reformations (c-MPRs) of the right coronary artery illustrating the 4-point scale used for image quality. From left to right: (A) the image was given a score 1 because of absence of any artifacts; (B) the image was given a score 2 because of mild blurring; (C) the image was given a score 3 because of structure discontinuity and moderate blurring; and (D) the image was given a score 4 because of doubling and discontinuity in the course of the vessel preventing diagnostic evaluation.](10.1177_1559325818805838-fig1){#fig1-1559325818805838}

Quantitative image quality was assessed evaluating objective parameters such as mean arterial attenuation, image noise, signal to noise ratio (SNR), and contrast to noise ratio (CNR). Mean arterial attenuation (in Hounsfield Units, HU) was measured by placing regions of interest (ROIs) in the ascending aorta at the pulmonary bifurcation and in the proximal segments of the right coronary artery, the left main artery, the left anterior descending artery, and the left circumflex artery. A circular ROI as large as possible was placed in the lumen of the target vessel taking care of not including vessel walls, calcifications, or plaques.^[@bibr13-1559325818805838]^ The attenuation values of 3 ROIs, 2 cm^2^ sized and placed in the air surrounding the patient, were averaged in order to calculate the background noise.^[@bibr14-1559325818805838]^ The mean attenuation of the central parts of pectoral muscles and the deep paraspinal muscles was measured on both sides, and values were averaged so that obtaining the muscle attenuation was useful for calculating the CNR.^[@bibr15-1559325818805838]^ Both SNR and CNR were calculated as follows using the above-mentioned parameters:

SNR = 

Mean arterial attenuation

Background noise

,
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The overall SNR and CNR were finally computed averaging the respective values for vascular structures. A comprehensive workflow is reported in [Figure 2](#fig2-1559325818805838){ref-type="fig"}.

![Objective image quality workflow. LM indicates left main coronary artery; LAD, left anterior descending coronary artery; CX, left circumflex coronary artery; RCA, right coronary artery; SNR, signal to noise ratio; CNR, contrast to noise ratio.](10.1177_1559325818805838-fig2){#fig2-1559325818805838}

Radiation Dose {#section6-1559325818805838}
--------------

For each patient, the dose length product (DLP) was recorded from the automatically generated patient protocol. The effective radiation dose was calculated by multiplying the total DLP by a conversion factor for the chest (k = 0.017 mSv × mGy^-1^ × cm^−1^) as previously suggested and adopted in large trials as effective dose.^[@bibr16-1559325818805838]^

Statistical Analysis {#section7-1559325818805838}
--------------------

Statistical analysis was conducted using R Core Team (version 3.03; Austria, Vienna) and a *P* ≤ .05 was considered statistically significant. Quantitative variables were expressed as mean ± standard deviation; categorical variables were expressed as percentage; and ordinal qualitative variables were expressed as median (1 quartile and 3 quartile). Data were tested for normality and homoscedasticity using the Shapiro-Wilk test and the Levene test, respectively. If data were normal and the variances were equal, the 1-way analysis of variance was performed and, in case of statistical significance, a Tukey post hoc test was utilized. If homoscedasticity was met but data were not gaussian, the Kruskal-Wallis test was applied and, in case of statistical significance, the Nemenyi test was used for multiple comparisons. Finally, if both normality and homoscedasticity were not met, the Friedman test was used, and the Conover test was considered as post hoc test in case of statistical significance.

Results {#section8-1559325818805838}
=======

Clinical characteristics of patients (age, sex, body mass index, pretest probability, and calcium score) are listed and compared in [Table 1](#table1-1559325818805838){ref-type="table"}: no significant difference was found among the 3 groups (*P* \> .05). The pretest probability of CAD for the entire population was 38.27 ± 28.21. The HR for the entire population was 57.88 ± 8.65 bpm, and the calcium score was 67.91 (range: 0-892). The effective dose was 2.09 ± 1.27 mSv in group A, 4.60 ± 2.78 mSv in group B, and 9.61 ± 5.95 mSv in group C, with a statistically significant difference (*P* \< .0001). The DLP was significantly lower in groups A and B (123 ± 74.96 mGy × cm and 270 ± 163.87 mGy × cm, respectively) in comparison to group C (565 ± 350.09 mGy × cm); *P* \< .0001 ([Figure 3A](#fig3-1559325818805838){ref-type="fig"}). Prescan HR was 51.85 ± 5.69 bpm for group A, 58.17 ± 8.27 bpm for group B, and 69.19 ± 8.12 bpm for group C (*P* \< .0001; [Figure 3B](#fig3-1559325818805838){ref-type="fig"}). The overall SNR and CNR were significantly higher in group A compared to group C (18.27 ± 0.32 vs 11.22 ± 0.50 and 16.75 ± 0.32 vs 10.17 ± 0.50, respectively; *P* = .001; [Figure 3C](#fig3-1559325818805838){ref-type="fig"}). Subjective quality, regardless of the effective HR during the examination, was similar in the 3 groups (median: 1 for group A, 1 for group B and 1.5 for group C, respectively, *P* = .34; [Figure 3D](#fig3-1559325818805838){ref-type="fig"}). Mean arterial attenuation was not significantly different among the 3 protocols, while background noise was lower in group A compared to group C (30.01 ± 8.87 HU vs. 44.23 ± 21.45 HU; *P* = .049; [Tables 2](#table2-1559325818805838){ref-type="table"} and [3](#table3-1559325818805838){ref-type="table"}). In detail, for ascending aorta, SNR was 17.92 ± 6.33 versus 10.55 ± 4.03, *P* = .01, and CNR was 16.40 ± 5.80 versus 9.50 ± 3.64, *P* = .0043; for left main coronary artery, SNR was 18.03 ± 6.40 versus 11.08 ± 4.33, *P* = .01 and CNR was 16.51 ± 5.86 versus 10.04 ± 3.96, *P* = .009; for left anterior descending artery, SNR was 18.25 ± 7.33 versus 11.11 ± 4.76, *P* = .016 and CNR was 16.73 ± 6.54 versus 10.07 ± 4.36, *P* = .016; for left circumflex artery, SNR was 18.74 ± 6.82 versus 11.45 ± 4.57, *P* = .008 and CNR was 17.22 ± 6.24 versus 10.41 ± 4.16, *P* = .008; for right coronary artery, SNR was 18.40 ± 6.97 versus 11.9 ± 5.13, *P* = .038 and CNR was 16.88 ± 6.48 versus 10.85 ± 4.77, *P* = .042 ([Table 3](#table3-1559325818805838){ref-type="table"}).

###### 

Clinical Patients Characteristics and Dosimetric Parameters.

![](10.1177_1559325818805838-table1)

                         Group A         Group B         Group C         *P* Value
  ---------------------- --------------- --------------- --------------- -----------
  Age                    53.54 ± 11.78   56.25 ± 10.54   59.19 ± 12.53   .49
  Male, %                57.7            45.8            50              .63
  BMI                    27.84 ± 4.30    25.94 ± 4.78    28.35 ± 5.45    .11
  Pre-test Probability   32.42 ± 26.67   43.77 ± 30.22   30.12 ± 20.45   .21
  HR                     51.85 ± 5.69    58.17 ± 8.27    69.19 ± 8.12    \<.0001
  DLP                    123 ± 74.96     270 ± 163.87    565 ± 350.09    \<.0001
  Effective dose         2.09 ± 1.27     4.60 ± 2.78     9.61 ± 5.95     \<.0001
  kV^a^                  120 (100-120)   120 (100-120)   120 (100-120)   .28
  Calcium score^b^       70.41 (0-892)   64 (0-602)      75.53 (0-520)   .44

Abbreviations: BMI, body mass index; HR, heart rate; DLP, dose length product.

^a^ Data are expressed as median (1 and 3 quartile).

^b^ Data are expressed as mean (minimum--maximum).

![(A) DLP, (B) HR, (C) SNR and CNR, and (D) subjective image quality in FLASH, SAS, and retrospective group. DLP indicates dose length product; HR, heart rate; SNR, signal to noise ratio; CNR, contrast to noise ratio; FLASH, high pitch mode; SAS, step and shoot mode.](10.1177_1559325818805838-fig3){#fig3-1559325818805838}

###### 

Image Quality Assessment.

![](10.1177_1559325818805838-table2)

                                     Group A           Group B           Group C          *P* Value
  ---------------------------------- ----------------- ----------------- ---------------- -----------
  Mean attenuation ROI                                                                    
   Ascending aorta                   498.97 ± 126.74   438.44 ± 137.23   402.07 ± 71.86   .13
   Left main coronary artery         501.67 ± 118.04   449.75 ± 135.73   422.16 ± 83.94   .23
   Left anterior descending artery   507.82 ± 151.67   436.07 ± 163.48   421.89 ± 97.59   .21
   Left circumflex artery            519.34 ± 123.82   430.35 ± 123.01   433.98 ± 80.75   .055
   Right coronary artery             510.94 ± 148.48   487.15 ± 173.67   451.59 ± 11.39   .70
   Background noise                  30.01 ± 8.87      35.24 ± 14.91     44.23 ± 21.45    .054
   Muscle                            40.95 ± 11.81     42.66 ± 9.00      38.77 ± 6.49     .52
  Signal to noise ratio                                                                   
   Ascending aorta                   17.92 ± 6.33      13.93 ± 5.65      10.55 ± 4.03     .014
   Left main coronary artery         18.03 ± 6.40      14.35 ± 5.75      11.08 ± 4.33     .012
   Left anterior descending artery   18.25 ± 7.33      13.97 ± 6.29      11.11 ± 4.76     .017
   Left circumflex artery            18.74 ± 6.82      13.81 ± 5.79      11.45 ± 4.57     .007
   Right coronary artery             18.40 ± 6.97      15.43 ± 6.67      11.9 ± 5.13      .049
   Overall SNR                       18.27 ± 0.32      14.30 ± 0.67      11.22 ± 0.50     .001
  Contrast to noise ratio                                                                 
   Ascending aorta                   16.40 ± 5.80      12.59 ± 5.33      9.50 ± 3.64      .005
   Left main coronary artery         16.51 ± 5.86      13.02 ± 5.41      10.04 ± 3.96     .012
   Left anterior descending artery   16.73 ± 6.54      12.63 ± 5.95      10.07 ± 4.36     .017
   Left circumflex artery            17.22 ± 6.24      12.47 ± 5.45      10.41 ± 4.16     .006
   Right coronary artery             16.88 ± 6.48      14.09 ± 6.34      10.85 ± 4.77     .053
   Overall CNR                       16.75 ± 0.32      12.96 ± 0.67      10.17 ± 0.50     .001
  Qualitative image quality^a^       1 (1-2)           1 (1-2)           1.5 (1-2)        .34

Abbreviations: SNR, signal to noise ratio; CNR, contrast to noise ratio.

^a^ Data are expressed as median (1 and 3 quartile).

###### 

Multiple Comparisons.

![](10.1177_1559325818805838-table3)

                                     *P* Value   *P* Value A versus B   *P* Value A versus C   *P* Value B vs C
  ---------------------------------- ----------- ---------------------- ---------------------- ------------------
  HR                                 \<.001      .004                   \<.0001                .0003
  DLP                                \<.001      .29                    \<.0001                \<.0001
  Effective dose                     \<.001      .29                    \<.0001                \<.0001
  Background noise                   .054        .73                    .049                   .13
  Signal to noise ratio                                                                        
   Ascending aorta                   .014        .17                    .01                    .21
   Left main coronary artery         .012        .13                    .01                    .26
   Left anterior descending artery   .017        .10                    .016                   .42
   Left circumflex artery            .007        .034                   .008                   .51
   Right coronary artery             .049        .34                    .038                   0.29
   Overall SNR                       .001        .077                   .001                   .077
  Contrast to noise ratio                                                                      
   Ascending aorta                   .005        .07                    .0043                  .23
   Left main coronary artery         .012        .11                    .009                   .27
   Left anterior descending artery   .017        .09                    .016                   .45
   Left circumflex artery            .006        .027                   .008                   .55
   Right coronary artery             .053        .34                    .042                   .31
   Overall CNR                       .001        .077                   .001                   .077

Abbreviations: HR, heart rate; DLP, dose length product; SNR, signal to noise ratio; CNR, contrast to noise ratio; A, maximum intensity projections (MIP); B, curved multiplanar reformations (c-MPR)R; C, conventional angiography; d, 3D volume rendering images.

A representative case of a 57-year-old-woman is reported: the effective dose using FLASH scan was 2.38 mSv, the anatomical details are well depicted, and the examination revealed a mixed mostly soft plaque with significant stenosis (\>50%) confirmed by further CA ([Figure 4](#fig4-1559325818805838){ref-type="fig"}).

![Computed tomography coronary angiography (CTCA) performed with high-pith spiral scan (FLASH) protocol in 57-year-old woman with hypertension and hyperlipidemia with atypical chest pain and family history of CAD. Prescan heart rate was 51 bpm, low pretest probability (8%), calcium score according Agatston method 134.1, and estimated radiation dose (ED) 2.38 mSv. A, MIP. B, c-MPR. C, Conventional angiography. D, Three-dimensional volume rendering images. The exam revealed (white arrows) a mixed mostly soft plaque which determines a significative stenosis (\>50%) at the ostium of the right coronary artery. Further conventional coronary angiography, followed by percutaneous transluminal coronary angioplasty (PTCA), confirmed this result.](10.1177_1559325818805838-fig4){#fig4-1559325818805838}

Discussion {#section9-1559325818805838}
==========

The development and spread of DSCT equipment has introduced new outlooks in cardiovascular imaging, exploiting the potential of 2 X-ray tubes working simultaneously at same or different energies.^[@bibr17-1559325818805838]^ The CTCA has been confirmed as a robust clinical tool for diagnosis and noninvasive assessment of CAD^[@bibr1-1559325818805838]^ and, more generally, coronary pathologies.^[@bibr3-1559325818805838],[@bibr4-1559325818805838]^ Several strategies have been developed to reduce radiation exposure during cardiac examination adjusting acquisition parameters (scan range, geometry of scanning, tube voltage, tube current modulation, pitch, and slice thickness) and using postprocessing filters able to reduce noise while preserving image quality.^[@bibr18-1559325818805838],[@bibr19-1559325818805838]^

Another exciting development that offers great promise to further increase CT potential is dual energy CT (DECT) that can be performed by 3 different technologies: dual-source DECT, single-source DECT, and detector-based spectral CT. Dual source DECT utilizes 2 X-ray tubes operating at different kV (low and high) and 2 detectors to obtain simultaneous DE acquisition and data processing. Single-source DECT uses a single X-ray tube that rapidly alternates between low and high energies (fast-switching) and a single detector that quickly registers information from both energies. In detector-based spectral CT, a single X-ray tube with full-dose modulation capabilities is paired with a detector made of 2 layers (sandwich detector) that simultaneously detects 2 energy levels.^[@bibr20-1559325818805838]^ The DECT offers the possibility to obtain virtual unenhanced images (VUEs), virtual monochromatic images at different energy levels, and material density images iodine (-water). In detail, VUE provides an unenhanced series from an enhanced acquisition thus saving dose exposure. Moreover, VUE images have been demonstrated to have lower image noise when compared to true enhanced images, and, especially in smaller patients, rapid switching DECT showed lower radiation dose when compared to single-energy CT scans, even if misconceptions about the radiation dose from 2 simultaneous X-ray projections and questions regarding the accuracy of additional DECT reconstructions have limited the widespread clinical implementation of this technology.^[@bibr21-1559325818805838]^

As far as DSCT is concerned, the most widespread dose-saving protocols (retrospective acquisition with ECG-gated tube current modulation, SAS mode, and FLASH mode) carry advantages and drawbacks.

Indeed, in retrospective ECG-gated CTCA, radiation dose has been considered very high^[@bibr22-1559325818805838],[@bibr23-1559325818805838]^ but, on the other hand, it is useful to assess cardiac function, since data acquisition covers all phases of the cardiac cycle; in addition, the flexibility and reliability of phase reconstruction is the highest when compared to other strategies.^[@bibr24-1559325818805838]^ The SAS mode is characterized by turning on the X-ray tube only at a predefined time point of the cardiac cycle, usually in mid-to-end diastole, while keeping the patient table stationary. This has resulted in a significant radiation dose reduction from over 20 mSv to around 2 mSv by confining the CT scan to the smallest possible window at only 1 distinct mid-diastolic phase of the cardiac cycle, while the X-ray tube is turned off during the rest of the cycle.^[@bibr25-1559325818805838],[@bibr26-1559325818805838]^ Nevertheless, it requires low and regular HR and provides only anatomical data not allowing left and right ventricle functional analysis.^[@bibr23-1559325818805838]^

Another low-dose technique that has been introduced for cardiac CTCA with the advent of second-generation DSCT equipped with two 128-slice acquisition detectors is FLASH mode.^[@bibr27-1559325818805838]^ This protocol is based on data acquisition prospectively triggered with the ECG, but, unlike SAS, data are acquired in a spiral mode while the table runs with a very high pitch of 3.2 to 3.4.^[@bibr28-1559325818805838]^ When FLASH mode is used, the entire heart can be scanned within one single cardiac cycle, usually during mid-to-end diastole with a dose for CTCA reduced at 1 mSv or below.^[@bibr12-1559325818805838],[@bibr29-1559325818805838]^ Our results showed a significant reduction in radiation dose in FLASH mode compared to SAS and, especially, compared to retrospective protocol.

Although literature data^[@bibr30-1559325818805838],[@bibr31-1559325818805838]^ demonstrated an image quality similar between retrospective protocol and SAS when using FLASH mode in patients with high HR without cardiac arrhythmia and with image acquisition time set at 20% to 30% of the R-R interval, in our preacquisition HR setting (\<60 bpm), a prospectively triggered acquisition was started at 60% of the R-R interval. However, with these acquisition parameters, image quality is maintained only when the HR does not change during the CTCA.^[@bibr10-1559325818805838],[@bibr32-1559325818805838]^ The use of our scan protocol recommendations to achieve optimal image quality at lowest dose, while maintaining diagnostic image quality on the whole relevant epicardial coronary tree, can substantially decrease the radiation dose in CTCA. In addition, these results emphasize the radiation dose reduction potential of HR-lowering medication (eg, β-blockers and ivabradine)^[@bibr33-1559325818805838],[@bibr34-1559325818805838]^ prior to CTCA in patients with HR \>65 bpm, which can consistently reduce radiation exposure. Their action is however not only indicated for HR reduction but it is also aimed to its stabilization during the acquisition.^[@bibr35-1559325818805838]^ Aggressive administration of HR-lowering medication before scanning may be considered in young patients to induce an HR \<55 bpm, which allows to use a FLASH protocol that is associated with a very low radiation dose.

Our study has some limitations; we included only patients in sinus rhythm, although there is evidence on the possibility to use the FLASH acquisition in patients with atrial fibrillation.^[@bibr36-1559325818805838],[@bibr37-1559325818805838]^ Another limitation is the relatively small number of patients in particular for retrospective acquisitions. Finally, the results of this study are valid only for a 128-slice DSCT scanner and cannot be extended to other CT systems characterized by higher effective temporal resolution.

In conclusion, the correct selection of a low-dose CTCA scan protocol according to HR with use of a 128-slice DSCT scanner results in a significantly reduced radiation dose and higher SNR and CNR. The major challenge is to obtain optimal image quality and an as-low-as-reasonably-achievable radiation exposure.
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